Recently, stabilization of RyR2 macromolecular complex by S107 (Rycal)—a benzothiazepine that prevents the dissociation calstabin2 from the RyR2 complex—showed therapeutic potential in vitro and in mouse models of AD in vivo. This evidence concerns the gene RYR2 and Alzheimer disease.